{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-244725","form_type":"8-K","ticker":"OSRH","cik":"0001840425","company_name":"OSR Holdings, Inc.","filed_at":"2024-10-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.967173+00:00","generated_at":"2026-05-30T09:48:00.613433+00:00","sec_items":["1.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Bellevue Life Sciences advances $300K loan to OSR Holdings at 3.96% annual interest","bullets":["Loan of $300,000 to OSR Holdings, target of proposed business combination, evidenced by promissory note.","Interest rate 3.96% per annum, compound semi-annually; principal and interest due October 25, 2025.","Funds to be used for working capital and other expenses of OSR Holdings.","Default provisions include failure to pay within 5 business days of maturity and bankruptcy events."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-244725","json":"https://secwatch.observer/filing/0001193125-24-244725.json","markdown":"https://secwatch.observer/filing/0001193125-24-244725.md","text":"https://secwatch.observer/filing/0001193125-24-244725.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840425/000119312524244725/0001193125-24-244725-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840425/000119312524244725/d889585d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T09:48:00.613433+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}